Evidence map›Paper›PMID 35366272›Full record

ArticlePathophysiology : the official journal of the International Society for Pathophysiology2021

Candesartan Normalizes Changes in Retinal Blood Flow and p22phox in the Diabetic Rat Retina.

Randa S Eshaq, Megan N Watts, Patsy R Carter, Wendy Leskova, Tak Yee Aw, Jonathan Steven Alexander, Norman R Harris

Open access · goldAbstract read
In one paragraph

Article in Pathophysiology : the official journal of the International Society for Pathophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Randa S EshaqDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.
Megan N WattsDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.
Patsy R CarterDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.
Wendy LeskovaDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.
Tak Yee AwDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.
Jonathan Steven AlexanderDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.ORCID 0000-0001-6975-3711
Norman R HarrisDepartment of Molecular & Cellular Physiology, Louisiana State University Health Sciences Center in Shreveport, Shreveport, LA 71130, USA.ORCID 0000-0001-7334-8153
Louisiana State University Health Sciences Center Shreveport · US

Funding

NIH HHS EY017599
6 · The paper itself

Abstract

Angiotensin II has been implicated in the progression of diabetic retinopathy, which is characterized by altered microvasculature, oxidative stress, and neuronal dysfunction. The signaling induced by angiotensin II can occur not only via receptor-mediated calcium release that causes vascular constriction, but also through a pathway whereby angiotensin II activates NADPH oxidase to elicit the formation of reactive oxygen species (ROS). In the current study, we administered the angiotensin II receptor antagonist candesartan (or vehicle, in untreated animals) in a rat model of type 1 diabetes in which hyperglycemia was induced by injection of streptozotocin (STZ). Eight weeks after the STZ injection, untreated diabetic rats were found to have a significant increase in tissue levels of angiotensin converting enzyme (ACE;

Indexed as

angiotensin IIcandesartandiabetesperfusionretinasuperoxide

Identifiers

PMID35366272
PMCPMC8830460
OpenAlexW3134978201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.